Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01466218 · ClinicalTrials.gov registry record
World Trade Center (WTC) CHEST
A clinical trial of Obstructive Sleep Apnea and Cardiovascular Disease, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 1,012
- Enrollment target
- 1
- Study location
NCT01466218: Completed study of Obstructive Sleep Apnea and Cardiovascular Disease, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01466218 is a study of Obstructive Sleep Apnea and Cardiovascular Disease that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,012 participants, above the 215-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (371% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01466218, a study of Obstructive Sleep Apnea and Cardiovascular Disease, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 1,012 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will evaluate the effects of World Trade Center (WTC) exposure in WTC responders 10-13 years following the events of 9/11. Prior studies have described persistent pulmonary function abnormalities in a significant portion of responders. The investigators study seeks to examine the relationship between pulmonary function abnormalities and other markers of chronic cardiopulmonary disease and further elucidate the pathophysiologic effects of exposure to inhaled particulate matter (PM) on 9/11. This study will provide critical information regarding risk of exposure to PM, risk factors for disease and potential for improvements in diagnosis and treatment.
Primary Outcome
To evaluate the persistent longitudinal effects of pulmonary function abnormalities (spirometry) and additionally demonstrate prevalence of impaired DLCO in WTC responders.
Conditions Studied
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,012 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-06 |
What the finished NCT01466218 record still lists
NCT01466218 is an observational study that tracks outcomes without assigning an intervention. Its 1,012 participants enrollment target places it among the larger protocols in the corpus, above the 215-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (371% higher).
The record links to 5 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 0 interventions.
NCT01466218 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01466218 about?
NCT01466218 is a clinical study titled "World Trade Center (WTC) CHEST". This project will evaluate the effects of World Trade Center (WTC) exposure in WTC responders 10-13 years following the events of 9/11. Prior studies have described persistent pulmonary function abnormalities in a significant portion of responders. The investigators study seeks to examine the relati...
What is the current status of trial NCT01466218?
This trial is currently completed. The enrollment target is 1,012 participants. The study started on 2011-11. Estimated completion is 2014-06.
What conditions does trial NCT01466218 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Cardiovascular Disease, Cardiac Disease, Pulmonary Disease, Cardiopulmonary Disease.
Who is sponsoring clinical trial NCT01466218?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01466218 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01466218's enrollment target sits among peer trials
1,012 6th of 155 higher than 150 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
RECRUITING · Phase 1
-
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
RECRUITING
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT06549595 · 1,018 participants · Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia